Caligan Partners as of June 30, 2025
Portfolio Holdings for Caligan Partners
Caligan Partners holds 17 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Verona Pharma Sponsored Ads (VRNA) | 26.1 | $136M | 1.4M | 94.58 | |
| Liquidia Corporation Com New (LQDA) | 19.4 | $101M | 8.1M | 12.46 | |
| Exelixis (EXEL) | 12.9 | $67M | 1.5M | 44.08 | |
| Agios Pharmaceuticals (AGIO) | 6.8 | $36M | 1.1M | 33.26 | |
| Merus N V (MRUS) | 6.6 | $35M | 657k | 52.60 | |
| Evolus (EOLS) | 5.9 | $31M | 3.3M | 9.21 | |
| Mineralys Therapeutics (MLYS) | 5.2 | $27M | 2.0M | 13.53 | |
| Revolution Medicines (RVMD) | 4.5 | $23M | 637k | 36.79 | |
| Anika Therapeutics (ANIK) | 2.9 | $15M | 1.4M | 10.58 | |
| Abivax Sa Sponsored Ads (ABVX) | 2.5 | $13M | 1.7M | 7.65 | |
| Y Mabs Therapeutics | 2.0 | $11M | 2.3M | 4.51 | |
| Rezolute Com New (RZLT) | 1.3 | $6.9M | 1.5M | 4.46 | |
| BioCryst Pharmaceuticals (BCRX) | 1.1 | $5.7M | 639k | 8.96 | |
| Sellas Life Sciences Group I Com New Call Option (SLS) | 1.0 | $5.0M | 2.3M | 2.19 | |
| Verrica Pharmaceuticals | 0.9 | $4.9M | 9.2M | 0.53 | |
| Tyra Biosciences (TYRA) | 0.3 | $1.8M | 190k | 9.57 | |
| Aura Biosciences (AURA) | 0.2 | $1.3M | 200k | 6.26 |
